You are here

To uk members, imatinib uk generic price

Hello everyone, in india we can get imatinib 400 mg tablets for one month for just 10 to 15 pounds.
What is the price of generic imatinib 400 mg in uk for 1 month.

Hii karthikey Last time chekup (last week) I asked doctor if imatinib fail 2 nd generations tki free / cost?? He said free.... Your tki? Imtinib?

In UK the National Health Service pays for the drugs which are used (from Government taxes); patients do not have to pay.

I am not sure how useful it is to compare pricing across nations of drugs such as Glivec (branded imatinib) and the various generic versions of imatinib-it is partly a function of the competition that exists in the market place and in specific countries i.e. number of suppliers of generics and as well what Big Pharma is able to get away with in terms of pricing.India of course seems to have had a specific history of litigation in the courts between Novartis and the Indian authorities regarding the applicability of the patent rights on Glivec;the manufacturer seems to have come off in second place in the legal battles and this led to an earlier introduction of imatinib generics and also more alternative generic brands within an apparently  more  deregulated environment.

As long ago as 2006 when I was dx with CML branded Glivec cost the National Health Service about £2000 per month and it seemed to have stayed at that level until 2017 when generally it was replaced by imatinib generic formulations.I have seen a figure for 2016 for USA that indicates Novartis were  charging upwards of £6200 per month for Glivec (106,000 US Dollars per annum). Figures for some of the EU countries were in some instances lower than UK especially France.

The introduction of generics does not lead to an immediate and drastic  decrease in price and in UK there will still be great variation as to how much the NHS will pay one producer of a generic compared to another and apparently it does special and confidential deals .Looking at the list of approved generics of imatinib in the BNF {British National Formulary) of NICE the drug tariff price of all of them is listed as  £787 for 30 tablets at 400mg(the price a community pharmacy will be reimbursed for dispensing I believe).The NHS indicative price for Accord, the cheapest, is a little over £200;prices for other generics are higher and Sandoz being the most expensive to the NHS it seems.I stand to be corrected by a pharmacist though.Some NHS trusts in 2017 onwards undertook internal studies to measure how much generics saved on their budget as against effectiveness and side effects of the new generic dispensed versus the previous Glivec:savings of up to £1800 per month were quoted depending on the generic contracted

Having experienced treatment for CML for ten years under the NHS and six years under private health insurance in UK (a long story not to be expanded) I have become interested in health administration and topics such as drug pricing.Prior to the Health and Social Care Act of 2012 we had primary care trusts and strategic health authorities but that led to a situation where the second line tki Dasatinib was only available as a postcode lottery as it was charged out at £38,000 per annum; nilotinib was too expensive for NICE to approve initially but then the producers reduced their prices to the level of imatinib and it was accepted.We  then had the introduction of Clinical Commissioning Groups (CCGs ) to which GP surgeries belonged to and in effect commissioned treatments from NHS trusts/hospitals.CML of course would be treated like other cancers by hospitals under special services funded by government say from NHS England-in effect tkis are paid for via a central budget but it might be that trusts receive a block of finance and have to cope within that resource that is granted.I did ask one of my NHS consultants to explain to me but he declined-it was it seems a sensitive topic of inadequate funding.So when you find it difficult to make that 3 monthly appointment or to get your prescription it might be useful to bear in mind that your haematologist or your NHS pharmacy might have resource constraints.

Currently the 2012 Health and Social Care Act is being amended  in Parliament under the latest proposals for Integrated Health and Social Care Boards- in England over 100 current CCGs are being replaced by 42 Boards who will commission care of all kinds (social care to be means tested of course and the cap applied) .I have not been able to ascertain whether cancer care and especially CML care will continue under the NHS as at present or whether this will be given as a responsibilty to the new Boards??Is anyone following this?

Regards

John